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Abstract: The possibility that pain perception and processing in the CNS results in cellular stress and may influence heat 
shock protein (HSP) expression was examined in a rat model of morphine dependence and withdrawal. Since activation of 
pain pathways result in exhaustion of growth factors, we examined the influence of cerebrolysin, a mixture of potent 
growth factors (BDNF, GDNF, NGF, CNTF etc,) on morphine induced HSP expression. Rats were administered   
morphine (10 mg/kg, s.c. /day) for 12 days and the spontaneous withdrawal symptoms were developed by cessation of  
the drug administration on day 13
th that were prominent on day 14
th and continued up to day 15
th (24 to 72 h periods). In  
a separate group of rats, cerebrolysin was infused intravenously (5 ml/kg) once daily from day one until day 15
th. In these 
animals, morphine dependence and withdrawal along with HSP immunoreactivity was examined using standard protocol. 
In untreated group mild HSP immunoreaction was observed during morphine tolerance, whereas massive upregulation of 
HSP was seen in CNS during withdrawal phase that correlated well with the withdrawal symptoms and neuronal damage. 
Pretreatment with cerebrolysin did not affect morphine tolerance but reduced the HSP expression during this phase.  
Furthermore, cerebrolysin reduced the withdrawal symptoms on day 14
th to 15
th. Taken together these observations sug-
gest that cellular stress plays an important role in morphine induced pain pathology and exogenous supplement of growth 
factors, i.e. cerebrolysin attenuates HSP expression in the CNS and induce neuroprotection. This indicates a new therapeu-
tic role of cerebrolysin in the pathophysiology of drugs of abuse, not reported earlier. 
Keywords: Morphine, heat shock proteins (HSP 72 kD), morphine tolerance, withdrawal symptoms, stress reaction, cerebro-
lysin, growth factors, pain perception, analgesia. 
INTRODUCTION 
  Pain perception and its regulation within the central 
nervous system (CNS) is complex and the cellular or mo-
lecular mechanisms of pain processing are still not well 
known [1-3]. Previous experiments from our laboratory sug-
gest that the micro-fluid environment of the brain and spinal 
cord plays important role in neuropathic pain [1, 2]. Thus, 
peripheral nerve lesion or ligation is associated with break-
down of the blood-spinal cord barrier (BSCB) to serum al-
bumin in several segments of the corresponding spinal cord 
within 1 to 10 weeks after the primary insult [1, 2]. In addi-
tion, the areas around the albumin leakage showed distinct 
morphological alterations in the neurons and the glial cells 
[1]. This suggests that alterations in the fluid microenviron-
ment of the CNS during pain processing and perception 
could be instrumental in causing structural changes in the 
spinal cord and may lead to an early neurodegeneration [1-4]. 
Therefore, in order to enhance patient care, new therapeutic  
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measures are needed to prevent these neurodegenerative 
changes in the CNS that are often associated with alterations 
in pain response or pain pathways. 
  Morphine dependence and withdrawal result in marked 
alterations in pain perception and/or modulation of pain 
pathways [5, 6]. However, the mechanisms of morphine de-
pendence or withdrawal induced structural and functional 
changes in the spinal cord are still not well characterized [7]. 
Previous reports from our laboratory show that morphine 
dependence and withdrawal in rats are often associated with 
alterations in the BBB function [8-11]. Furthermore, sponta-
neous withdrawal by cessation of morphine administration 
resulted in selective and specific neuronal and glial cell   
damage in the cerebral cortex, hippocampus, brainstem, 
thalamus and hypothalamus [8-12]. These changes were 
most pronounced in the brain within 48 to 72 h after the dis-
continuation of morphine injection [8-10, 12]. The probable 
mechanisms of this selective neurodegenerative changes 
during morphine withdrawal is still unclear. However,   
observed a profound increase in heat shock protein 72 kD 
(HSP) expression in the areas showing neuronal distortion 
and damage [9, 11, 12]. This indicates that cellular stress 
caused by morphine withdrawal may play important deter-224    Current Neuropharmacology, 2011, Vol. 9, No. 1  Sharma et al. 
mining role in the BBB dysfunction [13-18] and subse-
quently neuronal and glial damage in the brain [19-24]. It is 
therefore possible that drugs or therapeutic agents that are 
able to reduce the stress response caused by morphine de-
pendence or withdrawal could be able to attenuate these neu-
rodegenerative changes. 
  There are reasons to believe that several neurotrophic 
factors are actively involved in the process of psycho-
stimulant induced dependence and withdrawal responses 
within the CNS [7, 23-27]. Thus, infusion of brain derived 
neurotrophic factor (BDNF) or neurotensin-4 (NT-4) into the 
ventral tegmental area (VTA) of the midbrain attenuated 
morphine or cocaine induced changes in the neuronal mor-
phology and dendritic structures in animal models [25, 28]. 
But the local infusion of nerve growth factor (NGF) failed to 
affect morphine or cocaine induced changes in the VTA neu-
rons [29]. On the contrary, intracerebral infusion of neuro-
tensin-3 (NT-3) into the VTA potentiated the behavioral ef-
fects of cocaine [30]. Moreover, intra-VTA infusion of a 
neutralizing antibody for NT-3 also enhanced the cocaine 
induced behavioral responses [31]. These observations sug-
gest that the role of specific neurotrophic factors in the brain 
during drugs of abuse are still unclear and require further 
investigations. Since morphine, cocaine, amphetamine and 
other psychostimulants affects both neuronal and glial cell 
response within the brain [12-16, 32], a combination of 
BDNF, glial cell derived neurotrophic factors (GDNF) and 
other growth factors may be able to prevent or reduce the 
cellular and molecular responses of the brain following sub-
stance abuse. 
  Previous studies in our laboratory demonstrated that 
cerebrolysin, a combination of several neurotrophic factors 
(BDNF, GDNF, NGF, CNTF etc,) [33, 34] is able to reduce 
HSP 72 KD response and brain damage following heat stress 
in rats [35]. This suggests that a suitable combination of   
neurotrophic factors may reduce cellular stress to induce 
neuroprotection [36-38]. Thus, the possibility that cerebro-
lysin could influence morphine dependence and withdrawal 
induced HSP expression and cellular changes in the brain 
was examined in this investigation in our rat model of mor-
phine dependence and withdrawal.  
MATERIALS AND METHODS 
Animals 
  Experiments were carried out on Charles Foster male rats 
(200-250 g body weight) housed at controlled room tempera-
ture 21±1° C with 12 h light and 12 h dark schedule. Food 
and tap water were supplied ad libitum before the experi-
ments. All experiments were conducted according to Na-
tional Institute of Health (NIH) guidelines for care and han-
dling of experimental animals and approved by local Institu-
tional Ethics Committee. 
Morphine Dependence and Withdrawal 
 Morphine Sulfate (7, 8-Dihydro-4,5-epoxy-17-
methylmorphinan-3,6--diol sulfate; Cat. Nr. M8777, 
Sigma-Aldrich, Inc, Natick, MA, USA, Mol. Wt. 668.76, 
anhydrous) was dissolved freshly every day in sterile saline 
(30 mg/ml) 5-10 min before its administration in rats [11,12]. 
Each rat was administered 10 mg/kg Morphine subcutane-
ously once daily for 12 days to develop dependence [11]. 
Spontaneous withdrawal was induced by abrupt cessation of 
morphine injection on day 13 and animals were monitored 
for 72 h after morphine withdrawal [12]. 
Cerebrolysin Treatment 
  In another group of rats, cerebrolysin (Ebewe Neuro-
Pharma, Unterach, Austria) was administered intravenously. 
For this purpose, a polythene cannula (PE 25) was implanted 
into the right jugular vein aseptically 4 days before com-
mencement of the experiments [39]. The cannula was 
flushed regularly with heparinized saline to keep it patent 
[40]. Cerebrolysin (5 ml/kg) was infused through the cannula 
slowly (ca. 0.3 ml/min) daily once before the administration 
of morphine and continued even after cessation of morphine 
injection (from day 1 to day 15), i.e., up to 72 h after the 
withdrawal. This dose of cerebrolysin is known to induce 
neuroprotection in hyperthermia and/or brain injuries [33, 35].  
Parameters Measured 
  The following parameters were measured in cerebrolysin 
treated or untreated groups subjected to morphine depend-
ence and withdrawal. 
Morphine Analgesia 
  Morphine analgesia was evaluated using latency of tail-
flick response to radiant heat as nociceptive stimulus [11]. 
The animals were placed in individual Perspex restraint 
boxes (18x5x6 cm) having several round holes on their walls 
for free ventilation and the entire length of the tail remained 
outside the box [41]. The test was carried out by placing the 
middle part of the tail (keratinised scales were already re-
moved 24 h before) on an electrically heated tungsten wire 
(50 °C). The cut-off latency for tail-flick response was kept 
to 15 sec (see Table 2). 
  The control latency of tail-flick response in each rat was 
determined before morphine administration. Following mor-
phine administration, the analgesic tests were carried out at 
intervals of 10 to 15 min for 120 min. The latency response 
for each test was determined on the basis of average of three 
successive readings of the tail-flick response. The actual 
increase in latency response induced by morphine was calcu-
lated by deducting the control latency value from that ob-
served following morphine administration. The maximum 
percent response (MPR) was calculated using the formula 
[41, 42] as follows:  
% MPR = Test latency - Control latency ÷ cut-off time - con-
trol latency x 100 [41]. 
  The development of tolerance to analgesic response of 
morphine in rats occurred with single daily injection of mor-
phine (10 mg/kg, i.p.). The onset of development of toler-
ance was found to commence from the 4th day onwards and 
full tolerance developed by the 12th day of morphine treat-
ment [12]. 
Morphine Withdrawal Symptoms 
  The withdrawal symptoms were studied after the devel-
opment of complete tolerance to morphine analgesia. From 
our studies it was found that 12 days are needed to develop 
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withdrawal symptoms, the morphine administration was 
withdrawn on the 13
th day and the symptoms were noted 
daily for 72 h. To evaluate the spontaneous morphine with-
drawal symptoms, the rats were removed from their individ-
ual cages and placed in new cages. Each rat was observed  
for 30 min and the gross abnormal behavior, if any, were 
carefully recorded as previously demonstrated [43, 44] and 
as described below. 
(a) Wet-Shakes 
  These are vigorous shaking movements of the head 
and/or body of the rat similar to those produced by an animal 
when wet with water. The number of shakes during the 30 
min observation period was recorded. 
(b) Piloerection 
  This is the condition in which the fur on the body surface 
stood erect. The presence or absence of piloerection in 30 
min of observation period was noted. 
(c) Writhing 
  This syndrome consists of dragging of the abdomen 
along the floor of the cage with “sucking in" the abdominal 
wall or stretching and arching of the back, neither of which 
was accompanied with yawning. The presence or absence of 
this syndrome during 30 min observation period was re-
corded. 
(d) Teeth Chattering  
  This is an audible distinct sound and was identical to the 
gnawing sound produced by a rat while eating food pellets. 
Within the 30 min observation period, the presence or ab-
sence of such sound was noted. 
(e) Diarrhoea  
  The presence or absence of formless stool generally ad-
hered to the base of the tail was noted during 30 min obser-
vation period. 
(f) Aggressive Behavior 
  The aggressive behavior of the animal was observed by 
placing an untreated rat in the cage of the morphine-
withdrawn rats for 5 min. Immediately after placement, the 
animals started fighting with squeaking and biting attempts. 
Animals often show erect posture and facing each other like 
a boxing stance. The morphine withdrawn rats exhibiting 
such symptoms were termed as aggressive. 
(g) Loss of Body Weight 
  The body weight of the morphine withdrawn rats was 
compared with the weight of animals immediately before 
morphine withdrawal [11, 12].  
  The animals treated once daily morphine (10 mg/kg, i.p.) 
developed full tolerance on the day 12 as evident with their 
analgesic response, cataleptic response and hyperthermic 
response. In these morphine dependent rats, cessation of 
morphine injection resulted in the appearance of spontaneous 
withdrawal symptoms within 12 h [10-12]. The withdrawal 
symptoms were mainly observed to be the loss of body 
weight, "wet shake" phenomena, piloerection, writhing, teeth 
chattering, diarrhea and aggressive and jumping behavior   
[8-12]. These withdrawal symptoms continue to worsen with 
time. Thus, the withdrawal symptoms were aggravated at 24 
and 48 h after the cessation of morphine. No apparent reduc-
tion in the withdrawal symptoms was observed until 72 h later 
after the cessation of morphine administration [7-10, 45].  
Physiological Variables 
  The mean arterial blood pressure (MABP), heart rate, 
arterial pH and blood gases were examined in controls, mor-
phine treated and dependent rats as well as in rats subjected 
to morphine withdrawal according to standard procedures 
[39, 40]. 
Stress Symptoms 
  In morphine withdrawal rats, the stress symptoms were 
most severe following 24 and 48 h after the cessation of 
morphine administration. These symptoms include jumping, 
teeth chattering, writhing, circular motion and restlessness in 
the cages as evident with hyper-locomotor activity. The oc-
currence of diarrhea was most prominent on the 2nd day of 
morphine withdrawal. At post-mortem, many micro-
hemorrhages were noted in the mucosal wall of the stomach 
indicating formation of stress-ulcers [9-12]. 
Morphine Induced Changes in Body Temperature 
  Changes in the core body temperature following mor-
phine administration was recorded using a thermistor probe 
(Yellow Spring Co., USA) inserted through the rectum up to 
a length of 6 cm and it was held in place by wrapping an 
adhesive leucoplast around the base of the tail [18,19]. The 
probe was connected to a 6-channel telethermometer (Elec-
tromed, UK) that was powered through a voltage stabilizer. 
The calibration of the apparatus was checked every time 
before the start of the experiment [18-20]. 
Morphological Investigation 
  We examined HSP 72 kD immunoreactivity at light mi-
croscopy and ultrastructural changes in untreated or cerebro-
lysin treated rats subjected to morphine dependence or with-
drawal protocols as described above [12, 46-48]. For this 
purpose, at the end of the experiment, animals were anesthe-
tized deeply with Equithesin (3 ml/kg, i.p.) and the chest was 
opened rapidly, heart was exposed and the right auricle was 
incised. Immediately, after the incision of the right auricle, a 
butterfly needle (21 G) connected to perfusion system was 
inserted onto the left ventricle and the intravascular blood 
was washed out by perfusing about 50 ml of cold 0.1 M 
phosphate buffer (pH 7.0) followed by perfusion with cold 
150 ml 4 % paraformaldehyde in 0.1 M phosphate buffer as 
described earlier [46]. After perfusion, the animals were 
wrapped in an aluminum foil and placed overnight in a re-
frigerator at 4 °C. The next day, the brain and spinal cord 
was dissected out and placed in the same fixative for 1 week 
at 4 °C. After one week of tissue preservation, small pieces 
of the desired brain or spinal cord area were dissected out 
and about 40 m thick vibratome sections were cut and   
collected in different wells in 0.1 M phosphate buffer for 
immunostaining as free floating sections [48]. Other pieces 
of tissues from the identical brain areas were post-fixed in 
osmium tetraoxide and embedded in plastic (Epon 812) for 
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Heat Shock Protein (72 kD) Immunoreactivity 
  The HSP expression was examined in the brain and   
spinal cord using immunohistochemistry employing anti- 
bodies directed against HSP-72 kD (Amersham, England; for 
details see [48, 49].  
  In brief, tissue sections (40 m thick) were cut on a   
Vibratome (Oxford Instruments, UK) then transferred to the 
primary antibody solution (mouse anti-HSP antiserum 1:500) 
and normal swine serum (1:30 in phosphate buffer saline, 
PBS) and incubated free floating under agitation for 36 h at 
room temperature [46,48]. Immuno-complexes were local-
ized by incubating the sections for 6-7 min in a solution   
containing 75 g (microgram) of DAB and 30 ml of 30 % 
H2O2/100 ml of Tris-HCl buffer. The sections were washed 
in 0.15 M sodium cacodylate buffer and post-fixed for 20 
min in 2 % OsO4 dissolved in cacodylate buffer. They were 
then dehydrated in a graded series of ethanol, embedded   
in Epon between acetate foils and polymerized at 60°C   
for 48 h [48, 49]. The sections were examined under a   
light microscope for evaluation of the immunolabelling. For 
comparison, one section in each group was not osmicated to 
see the immuno-labelling against a light background. 
Transmission Electron Microscopy 
  Epon embedded tissue pieces from the untreated or   
cerebrolysin treated brain or spinal cord were sectioned for 
high resolution microscopy (about 1 m thick) and stained 
with toluidine blue [46,48,49]. The desired areas of the tissue 
block then further trimmed and ultrathin sections were cut  
on ultramicrotome (LKB, Sweden) using diamond knife. 
These ultrathin sections were collected on one-hole grid   
and some of them were counterstained with lead citrate and 
uranyl acetate before viewing under a Phillips or Hitachi 
Transmission Electron Microscope [46]. The EM grids were 
examined in a blinded fashion for neurovascular relations in 
cerebrolysin treated animals and compared with untreated 
group subjected to morphine dependence or withdrawal 
groups [see 11, 12]. In some group of untreated or cerebro-
lysin treated animals that were subjected to morphine de-
pendence and withdrawal, Lanthanum chloride (LaCl3; 2.5 
% solution) was added to the fixative during perfusion. Since 
La
3+ is an electron dense product, it can be visualized at 
TEM without any further processing [50]. Thus, La
3+ trans-
port across the microvessels can be easily examined in these 
groups [51, 52]. 
STATISTICAL ANALYSES OF DATA 
  The quantitative (physiological variables) data were ana-
lyzed using ANOVA followed by Dunnet’s test for multiple 
group comparison using one control group. The semi-
quantitative data (behavioral and morphological investiga-
tions) were analyzed using non-parametric Chi-Square test. 
A P-value < 0.05 was considered significant. 
RESULTS 
Effect of Cerebrolysin on Morphine Analgesia and   
Dependence 
  Cerebrolysin treatment did not affect morphine analgesia 
or dependence in rats. Thus, untreated group developed mor-
phine dependence from the day 4
th and onwards and cerebro-
lysin administration did not alter this pattern. In cerebrolysin 
treated animals, morphine administration resulted in gradual 
loss of analgesia from the 2
nd day onwards and on the 4
th day 
of injection achieved quite good morphine dependence (re-
sults not shown). On the day 10
th, complete dependence of 
morphine was seen in both untreated or cerebrolysin treated 
animals. No apparent differences in untreated or cerebrolysin 
treated animals were noted on the 12
th day of morphine 
treatment. 
Effect of Cerebrolysin on Morphine Withdrawal   
Symptoms 
  Cerebrolysin treatment markedly reduced the morphine 
withdrawal symptoms as seen on day 13, (24 h after mor-
phine withdrawal) and onwards (Table 1). Thus, in cerebro-
lysin treated group, rats showed milder withdrawal symp-
toms as compared to untreated rats during this phase of   
morphine withdrawal (Table 1). This effect of cerebrolysin 
was most pronounced on reducing aggressive behavior,   
teeth chattering, weight loss and body temperature changes 
(Table 1). This effect of cerebrolysin was most pronounced on 
the day 13 and 14 (days 1 and 2 after morphine withdrawal). 
Effect of Cerebrolysin on Morphine Induced   
Physiological Variables 
  Cerebrolysin treatment, slightly but significantly attenu-
ated alterations in physiological variables during morphine 
withdrawal. However, changes in these variables were not 
affected by cerebrolysin during the phase of morphine de-
pendence (Table 2). Thus, alterations in heart rate and respi-
ration were markedly reduced in cerebrolysin treated animals 
after morphine withdrawal (day 13 to 15). The magnitude 
and intensity of reduction in changes in these variables were 
most marked on the day 13 in cerebrolysin treated rats after 
morphine withdrawal (Table 2).  
Effect of Cerebrolysin on Morphine Induced HSP   
Expression 
  Cerebrolysin treatment markedly attenuated morphine 
dependence and/or withdrawal induced HSP 72 kD expres-
sion in the brain and spinal cord (Figs. 1-3). Normal rats did 
not show HSP expression in the CNS [11, 12]. However, 
HSP expression was seen markedly upregulated on day 12 of 
morphine dependence as compared to the control group (Fig. 
1). This expression of HSP was further enhanced following 
morphine withdrawal in different brain regions of the rats 
(Figs.  1 and 2).  This overexpression of HSP was most   
pronounced on day 2 of morphine withdrawal (Fig. 2). Cere-
brolysin treatment markedly attenuated the HSP expression 
seen on the morphine dependent rats on day 12 (Fig. 2 and 
3). Furthermore, cerebrolysin was also able to effectively 
reduce the expression of HSP in several brain and spinal 
cord regions following morphine withdrawal on day 1and 2 
(Figs. 2 and 3). 
Effect of Cerebrolysin on Morphine Induced   
Ultrastructural Changes 
  Cerebrolysin was able to reduce ultrastructural changes 
in the neuropil following morphine dependence or with-
drawal in rats as seen using transmission electron micros-
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the day 12 showed vacuolation in the neuropil with shrunken 
cells and vesiculation of myelin (Fig. 4). In this group, 
shrunken neurons and damaged synapses, axonal swellings 
are very common (Fig. 4). Membrane disruption and edema 
formation are also frequent in various brain and spinal cord 
in these morphine dependent rats (results not shown). These 
neuronal, axonal and synaptic changes were further en-
hanced following morphine withdrawal (Fig. 4). These ultra-
structural damages were most marked on day 2 of morphine 
withdrawal (Fig. 4). Accordingly, neuronal damage with 
distorted nucleus and nucleolus is quite frequent in rats in 
this group (Fig. 4). Damage of perineuronal glial cells and 
microglia are also very common and destruction to neuropil, 
membrane disruption and vacuolation of myelin are most 
frequent in these rats on the 2
nd  day of morphine withdrawal 
(Fig. 4). These ultrastructural neurophil changes either caused 
by morphine dependence or withdrawal (results not shown) 
were considerably reduced by cerebrolysin. Thus, in cerebro-
lysin treated animals the neuronal, axonal and myelin struc-
tures were better preserved than untreated rats following 
morphine dependence either on the day 12 or on the 2
nd  
day after morphine withdrawal as compared to untreated 
group. 
Effect of Cerebrolysin on Morphine Induced La
3+  
Extravasation 
  Cerebrolysin was able to markedly reduce infiltration of 
lanthanum across the brain and spinal cord microvessels 
caused by morphine dependence and or morphine with-
drawal (Table 3). In normal animals, lanthanum is confined 
within the capillary lumen [50] and the endothelial cells and 
basal lamina do not show any infiltration of the ionic tracer 
within the neuropil [12, 51, 52]. However, morphine de-
pendence results in infiltration of the electron dense lantha-
num tracer within the endothelial cell cytoplasm (Fig. 5) and 
even at the tight junctions that are normally closed (Fig. 5). 
On the other hand, morphine withdrawal induces widespread 
leakage of lanthanum within the endothelial cells and the 
tracer could also be seen frequently in the basal lamina and 
within the neuropil (Fig. 5). These effects of morphine with-
drawal on the lanthanum exudation in the brain were most 
prominent on the 2
nd day after withdrawal (Fig. 5).  Treat-
ment with cerebrolysin markedly attenuated the exudation of 
lanthanum across the microvessels in morphine dependent 
rats or following morphine withdrawal. The most marked 
effects of cerebrolysin in reducing lanthanum extravasation 
Table 1.  Effect of Cerebrolysin on Stress Symptoms During Morphine Dependence and Withdrawal 
Parameters Control  Morphine Dependence  Morphine Withdrawal 
    1st Day 
MD1 
10th Day 
MD10 
12th Day 
MD12 
12 h 
MWD0.5 
24h 
MWD1 
48h 
MWD2 
72h 
MWD3 
I. Stress symptoms  n=6 n=6 n=8 n=12 n=8  n=14 n=16 n=8 
A. Untreated 
Wet-Shakes    nil nil nil nil  4±2 8±3a 6±2  5±3 
Piloerection  nil nil nil nil  +++ +++++  ++++  +++ 
Writhing  nil nil nil nil  +++ +++++  ++++  +++ 
Teeth  chattering  nil nil nil nil  +++ +++++  +++++  +++ 
Diarrhoea  nil nil nil nil  +++ +++++  +++  nil 
Aggressive  behaviour  nil  nil  ?  ?  +++  +++++ +++++ +++++ 
Microhaemorrhages  in  stomach  nil  6±5 8±5 12±8 48±12  68±18# 85±14# 23±8# 
B. Cerebrolysin treated 5 ml/kg, i.v. 
Wet-Shakes    nil nil nil nil  4±2 4±2* 3±2* 3±2* 
Piloerection  nil nil nil nil  +++ +++++  ++++  +++ 
Writhing  nil nil nil nil  +++ +++++  ++++  +++ 
Teeth  chattering  nil nil nil nil  +++ +++++  +++++  +++ 
Diarrhoea  nil nil nil nil  +++ +++++  +++  nil 
Aggressive  behaviour  nil  nil  ?  ?  +++  +++++ +++++ +++++ 
Microhaemorrhages in stomach  nil  nil  2±1*  2±3*  6±2*  12±4*  16±8*  12±4* 
values are mean±SD; # = Many microhaemorrhages; a = significantly different (P<0.05) from Morphine withdrawal 12 h; +++ = mild, ++++ = moderate, +++++ = severe, ? =  
unclear, nil = absent,  
MD = morphine dependent; MWD = Morphine withdrawal; * = P <0.05, Chi Square test from untreated group; a = P <0.05, compared from MD12 group. 
For details see text. 228    Current Neuropharmacology, 2011, Vol. 9, No. 1  Sharma et al. 
Table 2.  Effect of Cerebrolysin on Physiological Variables During Morphine Dependence and Withdrawal 
Morphine Dependence  Morphine Withdrawal  Parameters Control 
1st Day 
MD1 
10th Day 
MD10 
12th Day 
MD12 
12 h 
MWD0.5 
24h 
MWD1 
48h 
MWD2 
72h 
MWD3 
II. Physiological variables n=6  n=8  n=8  n=6  n=8  n=8  n=6  n=6 
A. Untreated 
MABP  torr  110±8  122±8**  140±6**  148±5**  90±4**  128±6** 146±14** 94±8 
Arterial pH  7.38±0.02  7.36±0.08  7.35±0.07  7.36±0.05  7.35±0.06  7.36±0.08  7.34±0.05  7.36±0.07 
PaO2  torr  81.56±0.23  80.34±0.32  80.28±1.01 78.34±1.34 81.87±0.23  82.45±0.34** 82.67±0.31**  81.68±0.28 
PaCO2 torr  34.62±0.34  33.32±0.22  33.54±0.14  33.10±0.43  33.21±0.43  31.54±1.24  32.06±1.34  32.34±0.98 
Body Temp ° C  37.61±0.42  39.42±0.41**  38.64±0.51  38.42±0.31  39.54±0.23**  40.23±0.18**  39.28±0.11**  38.67±0.22 
Body weight (g)  288±14  289±8  340±12**  356±8**  350±8*  340±6*  320±8**  310±12* 
Heart rate beats/min  280±12  320±18*  330±12**  338±10**  304±8*  310±8*  308±7*  296±14 
Respiration  cycles/min  76±6 80±8  84±6**  86±7**  89±5* 94±4**  92±5** 80±8 
B. Cerebrolysin treated 5 ml/kg, i.v. 
 n=6  n=6  n=7  n=6  n=6  n=7  n=8  n=8 
MABP  torr  108±4  112±6  128±8**  138±8**  96±8**  108±7 126±8* 104±9 
Arterial pH  7.38±0.04  7.34±0.05  7.32±0.06  7.33±0.04  7.30±0.04  7.37±0.04  7.32±0.06  7.30±0.04 
PaO2 torr  81.36±0.13  81.34±0.23  80.64±0.61  79.04±0.84*  81.07±0.63  81.40±0.14  81.37±0.51  81.08±0.34 
PaCO2 torr  34.35±0.22  34.06±0.18  33.84±0.24  33.80±0.63  33.62±0.83  32.14±0.24  32.16±0.24  32.54±0.32 
Body Temp ° C  37.44±0.36  38.64±0.21* 38.34±0.41*  38.32±0.11*  39.44±0.13**  40.03±0.28* 39.48±0.31*  39.07±0.44 
Body weight (g)  290±12  294±10  328±10*  340±10**  336±12**  330±8**  326±10*  320±8** 
Heart rate beats/min  288±14  310±12*  320±8**  328±8**  318±6*  300±5*  288±10  286±8 
Respiration  cycles/min  72±8 76±4  80±4**  88±6**  80±8* 84±6* 80±5*  78±6 
values are mean±SD; a = significantly different (P<0.05) from Morphine withdrawal 12 h; nil = absent,; MD = morphine dependent; MWD = Morphine withdrawal 
For details see text. * P <0.05; ** P < 0.01, ANOVA followed by Dunnett's test for multiple group comparison from one control group. 
 
 
 
 
 
 
 
 
 
Fig. (1). Heat shock protein (HSP) 72 kD, a marker of cellular stress immunoreactivity in the spinal cord of morphine dependent rats on day 
12 (MD12) and following 2nd day of morphine withdrawal (MWD2). Expression of HSP 72 kD is seen in the ventral (a) and lateral (b) horns 
in C-5 segment (arrows) on the day 12 of morphine dependent rats. The magnitude and intensity of HSP expression is further increased on 
day 2 following morphine withdrawal in (MWD2, c,d, arrows). HSP expression is mainly seen in the cell cytoplasm. However, some nerve 
cells showed staining of cell nucleus as well. Bar = a.b = 40 m, c,d = 30 m [Reproduced with permission [12]. Cerebrolysin and Morphine Induced HSP Expression  Current Neuropharmacology, 2011, Vol. 9, No. 1    229 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Semiquantitative analysis of HSP 72 kD expression in the CNS and its modification with cerebrolysin. The number of HSP positive 
cells significantly increased in the cerebral cortex, hippocampus and in spinal cord following morphine dependence by day 12 (MD 12) as 
well as after morphine withdrawal day 1 (MW1) and day 2 (MW2) as compared to control group. Cerebrolysin (CBL) given daily in control 
animals did not induce HSP expression (CBL+ Cont) but is able to significantly reduce the HSP expression in both morphine dependent (MD) 
and morphine withdrawal (MW) rats on day 1 and 2. ** = P < 0.01 from control group, Chi Square test.  
across the microvessel were observed on the 2
nd day of mor-
phine withdrawal (Fig. 6). The incidence of perivascular 
edema in these groups was also reduced considerably by 
cerebrolysin treatment (Fig. 6). 
DISCUSSION 
  The salient new findings of this investigation clearly 
show that cerebrolysin, a mixture of various neurotrophic 
factors and peptides is able to attenuate morphine depend-
ence or withdrawal induced HSP response and neurotoxicity. 
This suggests that cerebrolysin could be used for the treat-
ment of drugs of abuse related CNS dysfunction, not re-
ported earlier.  Heat shock proteins (HSPs) are commonly 
known as stress proteins and are present in almost all neu-
ronal and non-neural cells in any organism [49, 53]. Their 
expression denotes largely cellular activation or cellular 
stress [48-50]. Over-expression of HSPs in the CNS could be 
seen either following trauma, hyperthermia, hypoxia, and 
stressful situations or following exposure to psychostimu-
lants, such as cocaine and methamphetamine [7-16]. It is 
believed that psychostimulant induced abnormal expression 
of HSP could reflect the state of specific cellular stress in the 
CNS. However, the functional significance of such findings 
is still not well known [9, 11-13, 45]. 
  Our laboratory has initiated a series of investigations on 
the functional significance of HSP expression in the CNS in 
various animal models of stress, trauma and exposure to 
drugs of abuse in relation to cell injury or repair [45-50]. We 
hypothesize that upregulation of inducible types of HSP ex-
pression (HSP 72 kD in the CNS represent profound cellular 
injury, stress or over activation of neuronal and non-neuronal 
cells [7, 35, 48-50, 53]. Thus, attenuation of HSP 72 kD   
response using drugs or neurotrophic factors could lead to 
neuroprotection [11, 12, 46-50]. A reduction in HSP expres-
sion in morphine dependence and withdrawal by cerebro-
lysin further supports this hypothesis.  Previous reports from 
our laboratory show that morphine withdrawal and metham-
phetamine administration induces HSP 72 kD immunoreac-
tivity in some brain areas. These brain regions are often   
associated with leakage of the serum albumin, a sign of   
the blood-brain barrier (BBB) disruption [7-13, 35, 45]. 
Thus, it is quite likely that disruption of the BBB caused by 
morphine and methamphetamine may lead to upregulation of 
HSP expression. 
  The present investigation further show that morphine 
withdrawal or dependence are associated with profound be-
havioral changes [11, 12], and cellular stress within the CNS 
as seen by marked overexpression of HSP 72 kD immunore-
activity. Interestingly, the brain areas of HSP expression in 
morphine dependence exhibited profound cellular damages 
that was also seen at the ultrastructural level. Although,   
during morphine dependent phase there is a reduction in   
the BBB permeability to proteins [11, 12], the cell changes 
and HSP expression is clearly seen in the brain of morphine 
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dependent animals. This suggests that abnormality of BBB 
dysfunction; either increase or decrease in nature is associ-
ated with brain damage [14-16, 54].  This hypothesis is fur-
ther confirmed in this investigation using electron micros-
copy. The ultrastructural observations showed shrinkage of 
neurons and non-neural cells during morphine dependence. 
This indicates that a decrease in the BBB function to ra-
dioiodine [11, 12] during morphine dependence is also asso-
ciated with cellular abnormalities in the brain [54]. This is 
further corroborated by our investigation of endothelial cells 
at the ultrastructural level using lanthanum tracer. Thus, in 
morphine dependent animals, infiltration of lanthanum was 
largely limited to the luminal endothelial cell membrane and 
cell cytoplasm. The abluminal cell membrane and tight junc-
tions appears to be largely intact. That is why lanthanum ion 
is not seen in the adjacent neuropil. This indicates that during 
morphine dependence, radiotracers are largely confined 
within the endothelial cells cytoplasm due to a defect in the 
luminal cell membrane permeability and could not enter into 
the brain compartment due to intact abluminal cell mem-
brane function. Thus, it appears that morphine dependence 
could be able to affect large luminal endothelial cell mem-
brane permeability [38]. However, this is a new feature that 
requires additional investigations.  
  When cell membrane function of the endothelial cells is 
compromised it could lead to various ionic, immunological, 
biochemical or molecular alterations in the adjacent neuropil. 
Thus, cellular damage seen in such situations could be asso-
ciated with cellular and/or molecular stress [12, 53]. This 
observation suggests that intoxication with drug like mor-
phine could lead to profound cellular stress in the CNS 
through altering cell membrane functions leading to neuro-
toxicity and neurodegenerative changes in the brain over 
time. These observations are in line with the idea that altera-
tions in endothelial cell membrane function could lead to cell 
damage.  Moreover, it is interesting to note that during mor-
phine dependent phase no apparent abnormalities or altera-
tions in sensory motor functions or in cognitive behavior 
may be noted in these animals. The signs of external stress 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (3). Light micrograph showing HSP expression in the cortex and thalamus is reduced by cerebrolysin treatment in morphine dependent 
rats on day 10 and 12 (MD 10, MD 12) and after morphine withdrawal day 1 and 2 (MWD1, MWD2). Only few scattered labeled neurons 
and dendrites particularly in the cell cytoplasm could be seen expressing weak HSP activity in cerebrolysin treated morphine dependent rats 
that was most prominent on day 10 (MD 10) as compared to day 12 (MD 12). On the other hand, cerebrolysin was able to prevent HSP ex-
pression in cortex and thalamus after morphine withdrawals day 1 and 2. Bar = 40 m. Cerebrolysin and Morphine Induced HSP Expression  Current Neuropharmacology, 2011, Vol. 9, No. 1    231 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (4). Ultrastructural changes in the nerve cell, myelin and neuropil in morphine dependent rats (day 12, MD 12) and following 2nd day of 
withdrawal (MWD2). A. Vacuolation (*), vesiculation of myelin (arrow) and degenerative changes in the neuropil are common in morphine 
dependent rat on day 12 (a). The magnitude and intensity of these structural changes, e.g., myelin vesiculation (arrows), membrane damage 
and vacuolation (') are much more frequent in animals following 2nd day of morphine withdrawal (A.b). One nerve cell showing dark and 
condensed cell cytoplasm in the ventral medial thalamic nucleus (c) is clearly seen on the 2nd day of morphine withdrawal in the rat. The 
surrounding neuropil showed many degenerative changes (arrows). B. Vacuolation and degenerative changes in the piriform cortex in one 
morphine dependent rat on day 12 (MD 12, B.a). These degenerative changes are much more prominent in animals on the 2nd day of mor-
phine withdrawal in the cortex (B.b) and in cerebellum (B.c). In the cerebellum, one Purkinje cell showed condensed cytoplasm with marked 
degenerative changes in the surroundings.  Vacuolation (*) and degenerative changes are clearly seen around the nerve cell and the granule 
cell or astrocyte (MWD2 c). Bar: A.a = 1 m, b,c = 0.8 m; B.a,b = 1.5 m, c = 0.8 m [Reproduced with permission [12]. 
Table 3.  Semiquantitative Data on Lanthanum Extravasation in Vascular Profiles in the Brain Following Morphine Dependence or 
Withdrawal in Control and Cerebrolysin (5 ml/kg, i.v.) Treated Rats 
Lanthanum Distribution in 80 Microvascular Profiles (Nr.) 
Inside Lumen  Endothelial Cell  
Cytoplasm 
Basal Lamina  Vesicular Profiles  Between the Tight 
Junctions# 
Type of Experiment  n 
Cerebellum  Cortex Cerebellum Cortex Cerebellum Cortex  Cerebellum cortex Cerebellum Cortex 
A. Untreated 
Control  5  76±4  78±2  0 0  0 0  6±4  8±5  0 0 
Morphine 12th day  6  54±4*  52±8*  12±6*  8±6*  8±4*  6±4*  18±6*  12±3  1±1  1±2 
MD12 
Morphine withdrawal 24 h  6  42±4*  48±6*  34±11*  26±14*  22±8*  16±7*  36±18*  28±14*  1±2  3±2 
MWD1 
Morphine withdrawal 48 h  5  34±12*  42±10*  48±8*  36±7*  46±14*  33±18*  44±12*  38±14*  2±2  2±3 
MWD2 
B. Cerebrolysin treated 
Control  5  78±2  78±5  0 0  0 0  0 8±4  0 0 
Morphine 12th day  6  14±6*  12±4*  4±2*  0  0  0*  0*  5±4  2±1  1±1 
MD12 
Morphine withdrawal 24 h  6  12±8*  18±4*  8±2*  2±1*  3±2*  1±1*  3±2*  3±2*  2±2  1±2 
MWD1 
Morphine withdrawal 48 h  5  8±6*  12±6*  10±4*  4±2*  4±3*  2±1*  4±2*  4±2*  2±3  2±2 
MWD2 
Data from 6 to 8 animals in each group; values are mean±SD;  
* = P <0.01, Chi-square test, Significantly different from control group, # = lanthanum is seen between the two tight junctions and stopped at the second one. 232    Current Neuropharmacology, 2011, Vol. 9, No. 1  Sharma et al. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (5). Representative examples of lanthanum extravasation across the blood-brain (a) and blood-spinal cord (b) barriers following 48 h 
after spontaneous morphine withdrawal in dependent rat. Infiltration of lanthanum is seen (arrowheads) across the endothelial cell of one 
microvessel from the cerebral cortex (a) and from the cervical spinal cord (b). Occurrences of many microvesicular profiles are clearly  
evident in the spinal cord endothelial cells (b). The tight junctions appear to be closed for lanthanum (arrows) in the cerebral (c) and spinal 
cord (d) microvessels. Edematous swelling of perivascular astrocytes is clearly visible (a-d). Bar = 500 nm (a); 600 nm (b), 300 nm (c); 400 
nm (d). 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (6). Effect of Cerebrolysin on lanthanum extravasation across the cerebral microvessels in morphine dependent animals on day 12 
(MD12) and following 2
nd day of morphine withdrawal (MWD2). At the ultrastructural level, cerebrolysin was able to thwart lanthanum ex-
travasation from lumen to the endothelial cell cytoplasm or in neuropil in MWD2 rat although; mild perivascular edema is also seen around 
this microvessel (*). Whereas, extravasation of lanthanum across the neuropil was largely abolished except in some very minor areas of the 
endothelial cell membrane (arrow head) in morphine dependent animal on the day 12(MD12). Signs of perivascular edema and structural 
changes are considerably reduced by cerebrolysin treatment.  
reactions are largely absent in these morphine dependent 
animals, but their brains and spinal cords exhibit pronounced 
HSP expression and cell injuries. This suggests that drugs of 
abuse, e.g., morphine, cocaine, methamphetamine or ecstasy 
(MDMA) could induce profound brain damage without 
showing any apparent signs of behavioral dysfunction. These 
findings suggest that cellular stress or tissue damage in the 
CNS could be unrelated to their narcotic activities. Our ob-Cerebrolysin and Morphine Induced HSP Expression  Current Neuropharmacology, 2011, Vol. 9, No. 1    233 
servations further show that cerebrolysin treatment markedly 
attenuated cell damage and HSP expression in morphine 
dependent animals. This indicates that exogenous supple-
ment of neurotrophic factors in combination, e.g. cerebro-
lysin could reduce cellular stress and brain damage during 
drug dependence.  
  Another important new finding of this investigation is 
that cerebrolysin is able to reduce stress symptoms markedly 
following morphine withdrawal. This suggests that cerebro-
lysin supplement could also reduce withdrawal symptoms of 
abused drugs, e.g., morphine. This idea is further supported 
by the fact that cerebrolysin treatment during morphine 
withdrawal prevented HSP activation in the brain and spinal 
cord. Obviously, if stress signals are not reaching the brain 
and spinal cord following morphine withdrawal, the cellular 
stress and concomitant increase in HSP 72 kD will be re-
duced considerably [46-50].  The mechanisms by which 
cerebrolysin is able to reduce morphine withdrawal symp-
toms and HSP expression is unclear from this investigation. 
However, available evidences suggest that morphine with-
drawal alter neurotrophic receptors activation and could also 
depletes stores of endogenous neurotrophins in the CNS [28, 
55-58, 61]. A reduction in cell and tissue stores of neurotro-
phins is likely to enhance the vulnerability of cellular injury 
to external stimuli [61-63]. This is clearly evident by the 
neuronal damage and breakdown of the endothelial cell 
membrane permeability to lanthanum during morphine with-
drawal. Thus, exogenous supplement of cerebrolysin during 
morphine withdrawal is able to reduce cell and tissue injuries 
and prevented HSP activation [35]. It is likely that exoge-
nous administration of cerebrolysin could replace at least 
partially the cellular stores of neurotrophins in the brain dur-
ing morphine withdrawal resulting in alleviating stress sig-
nals, cell injury and downregulation of HSP expression. 
  A reduction in HSP expression during morphine depend-
ence or withdrawal by cerebrolysin appears to be neuro- 
protective in nature [45-50, 61-63]. Thus, cerebrolysin 
treatment not only reduced HSPs expression in the brain and 
spinal cord after morphine dependence or withdrawal, but 
also reduced the neuronal, glial and endothelial cell injuries. 
This suggests that overactivation of inducible type of HSP 
(72 kD) represent adverse life threatening injury signals [48-
50]. This is supported by our observations that HSP expres-
sion is seen in the areas showing neuronal distortion, vacuo-
lation or exhibiting edematous changes in the neuropil. 
Cerebrolysin treatment attenuated HSP expression and also 
resulted in marked neuroprotection. We speculated that   
the expression of inducible isoform of HSP 72 kD that   
is normally not present in the cells when activated by   
any adverse stimuli may represent cellular overactivation or 
cellular stress reaction [48, 50]. However, HSP 70 and other 
isoforms of stress proteins, e.g., HSP 27, HSP 90 that are 
normally expressed constitutively in cells and tissues could 
be neuroprotective in nature when they are upregulated fol-
lowing stress or injury signals [46-50, 61-63]. 
  Previous reports from our laboratory also show that ex-
ogenous supplement of brain derived neurotrophic factors 
(BDNF) in spinal cord injury prevents the overexpression   
of trauma induced HSP 72 kD activity and subsequently   
reduces microvascular permeability disturbances, edema 
formation and cell damage [35-38, 45-50, 61-63]. This   
neuroprotective activity of BDNF in spinal cord injury was 
further strengthened when a combination of BDNF and glial 
cell line derived neurotrophic factor (GDNF) was given in 
combination [35-38, 61-65]. These observations suggest that 
during CNS injuries an exogenous supplement of both the 
brain and glial derived neurotrophic factors are needed to 
achieve some degree of neuroprotection. The present study 
further confirms this hypothesis and clearly indicates that 
cerebrolysin that represents a combination of neurotrophic 
factors from both the neurons and glial cells has profound 
neuroprotective efficacy in drug dependence and withdrawal 
induced brain damage. 
  Taken together, our observations are the first to show that 
cerebrolysin is able to attenuate cell injury in morphine de-
pendence and withdrawal and thus could be an important 
therapeutic tool to achieve neuroprotection in morphine and 
other psychostimulant induced neurotoxicity. This neuropro-
tection caused by cerebrolysin following morphine depend-
ence and withdrawal is achieved by reducing cellular stress 
in the CNS as evident with downregulation of HSP activity.  
In conclusion, our observations point out a new role of cere-
brolysin for the treatment of drugs of abuse induced disor-
ders in clinical situations. However, further research is 
needed to find out a clinical role of cerebrolysin in patients 
affected by drugs of abuse syndrome. 
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